Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$38.13 - $76.93 $396,552 - $800,072
-10,400 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$60.19 - $97.37 $625,976 - $1.01 Million
10,400 New
10,400 $778,000
Q4 2019

Feb 13, 2020

SELL
$57.95 - $66.61 $1.3 Million - $1.5 Million
-22,500 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$60.08 - $88.17 $1.35 Million - $1.98 Million
22,500 New
22,500 $1.35 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.